[CongressionalLC Bills129 119th1024 Congress]House [FromResolution 1295 th th nd By:RepresentativesCooperofthe45 ,Flemingofthe114 ,Parisofthe142 ,andMartinez th of the U.S.111 A RESOLUTION Recognizing the first full week in May as Tardive Dyskinesia Awareness Week 2026;

Governmentand Publishingfor Office]other [H.purposes.

Res.WHEREAS, serious mental illnesses like bipolar disorder, major depressive disorder, and schizophrenia often require treatment with antipsychotic medications for effective management, and antipsychotic prescribing rates continue to rise;

1265and IntroducedWHEREAS,whileprolongedantipsychoticusemaybeessentialforthetreatmentofcertain inconditions, Houseit (IH)]is <DOC>associated 119thwith CONGRESStardive 2ddyskinesia Session(TD), H.a condition marked by uncontrollable,abnormal,andrepetitivemovementsoftheface,torso,limbs,orextremities;

RES.and WHEREAS,peopleathigherriskofTDincludethoseolderthan55years,Blackindividuals, women,individualswithmoodorsubstanceusedisorders,intellectualdisabilities,orcentral nervous system injuries, and those with high cumulative antipsychotic exposure;

1265and ExpressingWHEREAS, supportapproximately for60 thepercent designation of the weekestimated of800,000 Mayadults 3,in 2026,the throughUnited MayStates 9,living 2026,with asTD ``Tardiveremain Dyskinesiaundiagnosed; Awareness Week''.

_______________________________________________________________________and INeven THEmild HOUSETD OFsymptoms REPRESENTATIVEScan Maybe 7,stigmatizing 2026and Mr.H.

PetersR. (for himself, Mr.

Bilirakis,1295 Mr.- 1 - LC 129 1024 impair physical, social, and emotional well-being, underscoring the urgency of early screening, detection, and intervention;

Mullin,and WHEREAS, the American Psychiatric Association recommends routine TD screening in their clinical guidelines for antipsychotic treatment, and Mr.individuals treated with antipsychotics or experiencing abnormal movements should consult their healthcare providers to assess TD risk, receive TD screenings, and determine appropriate treatment together;

Beanand WHEREAS, FDA-approved treatments for TD can provide options for symptom management and improved quality of Florida)life submittedfor themany followingindividuals resolution;living with TD.

whichNOW,THEREFORE,BEITRESOLVEDBYTHEHOUSEOFREPRESENTATIVESthat was referred to the Committeemembers onof Energythis andbody Commercerecognize _______________________________________________________________________the RESOLUTIONfirst Expressingfull supportweek forin theMay designationas ofTardive theDyskinesia weekAwareness ofWeek May2026, 3,prioritizing 2026,TD throughawareness, Mayeducation, 9,and 2026,routine asscreenings ``Tardiveto Dyskinesiaimprovecareforindividualsprescribedantipsychoticssupportsthehealthandwell-beingof AwarenessGeorgia's Week''.citizens.

WhereasBEITFURTHERRESOLVEDthattheClerkoftheHouseofRepresentativesisauthorized many people living with serious mental illnesses (for example, bipolar disorder, major depressive disorder, schizophrenia, and schizoaffectivedirected disorder)to ormake gastrointestinalappropriate disorderscopies (forof example,this gastroparesis,resolution upsetavailable stomach,for nausea,distribution andto vomiting)the maypublic be treated with medications that work as dopamine receptor blocking agents, including antipsychotics and antiemetics;the press.

Whereas,H. while ongoing treatment with these medications can be necessary, prolonged use may be associated with tardive dyskinesia (TD), an involuntary movement disorder that is characterized by uncontrollable, abnormal, and repetitive movements of the face, torso, limbs, and fingers or toes;

WhereasR. even mild symptoms of TD can impact people physically, socially, and emotionally;

Whereas1295 it- is2 estimated- that TD affects approximately 600,000 people in the United States, and approximately 60 percent of people with TD have not been diagnosed, making it important to raise awareness about the symptoms;

Whereas it is important that people taking these medications be monitored for TD by a health care provider, and regular screening for TD is recommended by the American Psychiatric Association;

Whereas clinical research has led to approval of treatments for adults with TD by the Food and Drug Administration, and recognition and treatment of TD can make a positive impact in the lives of many people experiencing psychotic and mood disorders;

and Whereas the House of Representatives can raise awareness of TD among the public and medical community:

Now, therefore, be it Resolved, That the House of Representatives-- (1) expresses support for the designation of ``Tardive Dyskinesia Awareness Week'';

and (2) encourages each individual in the United States to become better informed about and aware of tardive dyskinesia.

<all>